Ad Scientiam:企業の製品パイプライン分析

◆英語タイトル:Ad Scientiam - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2362711PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare professionals and pharmaceutical companies. The company’s solution finds application in the areas of Parkinson disease, Asthma, Atopic Dermatisi, Insomnia, Multiple Sclerosis, Oncology and Alzheimer’s disease among others. It also operates an office in the US. Ad Scientiam is headquartered in Paris, Ile de France, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ad Scientiam
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Ad Scientiam Company Overview
Ad Scientiam Company Snapshot
Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Ad Scientiam – Pipeline Analysis Overview
Ad Scientiam – Key Facts
Ad Scientiam – Major Products and Services
Ad Scientiam Pipeline Products by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam Pipeline Products Overview
Actisleep
Actisleep Product Overview
CARDICARE
CARDICARE Product Overview
CARDICARE Clinical Trial
Mobile Application – Alzheimer’s
Mobile Application – Alzheimer’s Product Overview
Mobile Application – Asthma
Mobile Application – Asthma Product Overview
Mobile Application – Insomnia
Mobile Application – Insomnia Product Overview
Mobile Application – Major Depressive Disorder
Mobile Application – Major Depressive Disorder Product Overview
Mobile Application – Major Depressive Disorder Clinical Trial
Mobile Application – Oncology
Mobile Application – Oncology Product Overview
Mobile Application – Parkinson’s
Mobile Application – Parkinson’s Product Overview
Mobile Application – Rheumatoid Arthritis
Mobile Application – Rheumatoid Arthritis Product Overview
Mobile Application – Schizophrenia
Mobile Application – Schizophrenia Product Overview
MSCopilot Mobile App
MSCopilot Mobile App Product Overview
Ad Scientiam – Key Competitors
Ad Scientiam – Key Employees
Ad Scientiam – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Ad Scientiam, Recent Developments
Oct 28, 2019: Ad Scientiam tracks valuable digital biomarkers for clinical research
Jan 29, 2019: Ad Scientiam selected for Pfizer Acceleration Program
Nov 14, 2018: Ad Scientiam announces clinical validation of its MSCopilot solution
Nov 14, 2018: Ad Scientiam, a french startup hosted at the Brain & Spine Institute (paris), announces clinical validation of its MSCopilot solution
Jul 18, 2018: MyHBP, application dedicated to the monitoring of benign prostatic hypertrophy
Jul 18, 2018: TLM : new version of MSCopilot
Jul 17, 2018: Ad Scientiam selected for EIT Health GoGlobal Canada Programme
Jun 08, 2018: Altran accompanies Ad Scientiam on the European compliance of MSCopilot
Jun 01, 2018: The 16 Health start-ups selected by Product Market Fit
May 30, 2018: MSCopilot is evolving for World MS Day
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Ad Scientiam Pipeline Products by Equipment Type
Ad Scientiam Pipeline Products by Indication
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam, Key Facts
Ad Scientiam, Major Products and Services
Ad Scientiam Number of Pipeline Products by Development Stage
Ad Scientiam Pipeline Products Summary by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam Ongoing Clinical Trials Summary
Actisleep - Product Status
Actisleep - Product Description
CARDICARE - Product Status
CARDICARE - Product Description
CARDICARE - Impact of a Digital Solution (CardiCare) on Cardiorespiratory Fitness Improvement in Patients Discharged from a Phase 2 Cardiac Rehabilitation Following an Acute Coronary Syndrome
Mobile Application - Alzheimer’s - Product Status
Mobile Application - Alzheimer’s - Product Description
Mobile Application - Asthma - Product Status
Mobile Application - Asthma - Product Description
Mobile Application - Insomnia - Product Status
Mobile Application - Insomnia - Product Description
Mobile Application - Major Depressive Disorder - Product Status
Mobile Application - Major Depressive Disorder - Product Description
Mobile Application - Major Depressive Disorder - Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale
Mobile Application - Oncology - Product Status
Mobile Application - Oncology - Product Description
Mobile Application - Parkinson’s - Product Status
Mobile Application - Parkinson’s - Product Description
Mobile Application - Rheumatoid Arthritis - Product Status
Mobile Application - Rheumatoid Arthritis - Product Description
Mobile Application - Schizophrenia - Product Status
Mobile Application - Schizophrenia - Product Description
MSCopilot Mobile App - Product Status
MSCopilot Mobile App - Product Description
Ad Scientiam, Key Employees
Ad Scientiam, Other Locations
Glossary

★海外企業調査レポート[Ad Scientiam:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Odonate Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Odonate Therapeutics LLC (Odonate) is a company that develops medicines for the treatment of cancer. It develops best in class medicines that enhance and extend the lives of patients suffering from cancer. Odonate’s lead product candidate, tesetaxel, is a novel orally administered taxane use …
  • Gaia, Inc. (GAIA):企業の財務・戦略的SWOT分析
    Gaia, Inc. (GAIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Brigham and Women’s Hospital:企業のM&A・事業提携・投資動向
    Brigham and Women's Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brigham and Women's Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Coherent Inc (COHR):企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ramot:製薬・医療:M&Aディール及び事業提携情報
    Summary Ramot is a business engagement center of Tel Aviv University that offers technology transfer services. The center manages new technologies from university laboratories to the domestic and commercial markets. It also offers services which include research and development programs, securing ap …
  • Amtek Auto Limited:企業のM&A・事業提携・投資動向
    Amtek Auto Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtek Auto Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • FLX Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary FLX Bio Inc (FLX Bio) focuses on the discovery, development and commercialization of novel immuno-oncology agents. The company’s pipeline product, FLX925 is a drug targeting the FLT3 mutations which is found in patients with acute myeloid leukemia (AML). FLX925 simultaneously targets a secon …
  • Netmedia S.A.
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Timken Company
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析
    CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sasol Ltd (SOL):企業の財務・戦略的SWOT分析
    Sasol Ltd (SOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Puma Biotechnology Inc (PBYI):製薬・医療:M&Aディール及び事業提携情報
    Summary Puma Biotechnology Inc (Puma) is a biopharmaceutical company that develops novel therapeutics for the treatment of cancer. The company develops and commercializes three drug candidates, namely, PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Its pipeline portfolio also enc …
  • Mckesson Europe AG (CLS1):製薬・医療:M&Aディール及び事業提携情報
    Summary Mckesson Europe AG (Mckesson Europe), formerly known as Celesio AG, is a provider of logistics and services to healthcare and pharmaceutical sectors across Europe. The company is involved in providing distribution solution to its wholesale, institutional and retail customers and delivering p …
  • MonTa Biosciences ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary MonTa Biosciences ApS (MonTa Biosciences) is a biotechnology company that develops and commercializes immuno-oncology therapeutics for cancer therapy. Its pipeline products include MBS2, and MBS5 used for the treatment of cancer and infectious diseases. The company’s technology is based on T …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野:企業M&A・提携分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company’s pr …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Taisei Lamick Co., Ltd.:企業の戦略・SWOT・財務情報
    Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taisei Lamick Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MPI Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MPI Research Inc (MPI) is a drug development contract research organization that offers contracted scientific research services. The organization’s services comprise drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services and medical devi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆